Is mood chemistry?
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
The chemical hypothesis of depression suggests that mood disorders are caused by a chemical imbalance in the brain, which can be corrected by antidepressant drugs. However, recent evidence indicates that problems in information processing within neural networks, rather than changes in chemical balance, might underlie depression, and that antidepressant drugs induce plastic changes in neuronal connectivity, which gradually lead to improvements in neuronal information processing and recovery of mood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that problems of information processing within neuronal networks associated with neuromorphological changes underlie depression (Castrén, 2005).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Castrén, 2005
In the citing paper
“Conversely, when neuroplasticity is enhanced (e.g., by treatment), synaptic contacts increase, enhancing adaptability by allowing activity-dependent competition to stabilize the neural structures that best represent internal and external conditions 24-26 .”
From Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model (2020) · cites this paper as [24]
In the citing paper
“The iPlasticity concept proposes that psychedelics may induce a permissive state for neuroplasticity that requires the stabilization of new connections guided by network activity produced by experience (Castrén, 2005).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Castrén, 2005
Citations
Cites
The brainweb: phase synchronization and large-scale integration
Varela, F., Lachaux, J.-P., Rodriguez, E., & Martinerie, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067550 · Cited by 4,761
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Synaptic Activity and the Construction of Cortical Circuits
Katz, L. C., & Shatz, C. J. (1996) · Science · doi:10.1126/science.274.5290.1133 · Cited by 3,048
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Cited by
Items 401–500 of 576
Dudok, J. J., Groffen, A. J. A., Witter, M. P., Voorn, P., & Verhage, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.071 · Cited by 12
Kojic, M., Saelens, J., Kadriu, B., Zarate, C. A., & Kraus, C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_313 · Cited by 13
An extended study of dimeric phenyl tropanes
Nielsen, S., Pedersen, C. M., Hansen, S. G., Petersen, M. D., Sinning, S., Wiborg, O., Jensen, H. H., & Bols, M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.007 · Cited by 16
Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects
Mora, F., Ramos‐Quiroga, J. A., Baca‐García, E., Crespo, J. M., Gutiérrez-Rojas, L., Madrazo, A., Pérez-Costillas, L., Sáiz, P. A., Tordera, V., & Vieta, E. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1623659 · Cited by 11
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 12
Effect of Gallic Acid and Endurance Exercise Training on BDNF in a Model of Hippocampal Degeneration
Rafiei, S., Bazyar, Y., & Edalatmanesh, M. A. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.1.1 · Cited by 11
Araya, A. V., Rojas, P., Fritsch, R., Rojas, R., Herrera, L., Rojas, G., Gatica, H., Silva, H., & Fiedler, L. (2006) · Endocrine · doi:10.1007/s12020-006-0007-2 · Cited by 12
Management of Painful Physical Symptoms Associated With Depression and Mood Disorders
Wise, T. N., Arnold, L. M., Maletic, V., & Ginsberg, D. L. (2005) · CNS Spectrums · doi:10.1017/s1092852900028121 · Cited by 11
Vigilance state dissociation induced by 5-MeO-DMT in mice
Bréant, B. J. B., Prius-Mengual, J., Andrews, A., Hoerder‐Suabedissen, A., Patel, J., Bannerman, D. M., Sharp, T., & Vyazovskiy, V. V. (2026) · Communications Biology · doi:10.1038/s42003-025-09412-x · Cited by 10
Pałucha-Poniewiera, A. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173454 · Cited by 10
Sewall, K. B., Caro, S. P., & Sockman, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059857 · Cited by 10
The dilemma of treatments for epileptic patients with depression
Yang, Y., Gao, X., & Xu, Y. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.959122 · Cited by 10
Shao, L., Hewitt, M. C., Wang, F., Malcolm, S. C., Ma, J., Campbell, J. E., Campbell, U. C., Engel, S. R., Spicer, N. A., Hardy, L. W., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.016 · Cited by 10
Computational methods for the discovery of mood disorder therapies
López-Vallejo, F., Peppard, T. L., Medina‐Franco, J. L., & Martínez‐Mayorga, K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.637106 · Cited by 9
The effectiveness of acupuncture for chronic pain with depression: A systematic review protocol
Yang, Z., Zhao, L., Xie, X., Xu, T., Zhang, Y., Wang, X., Du, J., Wang, Z., Zhou, M., Li, Y., et al. (2017) · Medicine · doi:10.1097/md.0000000000008800 · Cited by 11
Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy
Lepow, L., Morishita, H., & Yehuda, R. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021012 · Cited by 11
Depression Viewed as a GABA/Glutamate Imbalance in the Central Nervous System
Joanna, M. W., Pałucha-Poniewiera, A., Nowak, G., & Pilc, A. (2012) · InTech eBooks · doi:10.5772/31450 · Cited by 8
Input-output relation of midbrain connectomics in a rodent model of depression
Tong, Y., Cho, S. G., Coenen, V. A., & Döbrössy, M. D. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.124 · Cited by 8
Impact of GRIK4 gene polymorphisms on cognitive dysfunction in patients with major depression
Pu, M. J., Wang, X., & Zhang, J. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.11.009 · Cited by 9
Long, S., Fang, J. S., Shu, H., Xia, D., Wang, Z.-Q., Mi, W., Zhang, X., & Li, C. (2022) · BioPsychoSocial Medicine · doi:10.1186/s13030-022-00245-2 · Cited by 8
Shao, L., Hewitt, M. C., Wang, F., Malcolm, S. C., Ma, J., Campbell, J. E., Campbell, U. C., Engel, S. R., Spicer, N. A., Hardy, L. W., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.019 · Cited by 8
Liu, Z., Chen, B., Xiang, S., & Hu, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02008-9 · Cited by 7
Insomnia and treatment-resistant depression
Lin, W., & Winkelman, J. W. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.01.005 · Cited by 8
Machaj, W., Podgórski, P., Maciaszek, J., Piotrowski, P., Szcześniak, D. M., Korbecki, A., Rymaszewska, J., & Zimny, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185507 · Cited by 8
The Importance of Glia in Dealing with Stress
Woodbury-Fariña, M. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.08.003 · Cited by 7
Fiszbein, A., Schor, I. E., & Kornblihtt, A. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800781-5.00011-6 · Cited by 8
Chiamulera, C., Benvegnù, G., Piva, A., & Paolone, G. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105648 · Cited by 7
Is Depression a Brain Disorder? Neuroscience in Mental Health Care
Helén, I. (2011) · Advances in medical sociology · doi:10.1108/s1057-6290(2011)0000013010 · Cited by 7
Therapeutic potential of cannabidiol in depression
Guldager, M. B., Filho, A. M. C., Biojone, C., & Joca, S. R. L. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.06.001 · Cited by 7
Depression Treatment: Is There a Role for Botulinum Toxin Type A?
Rodríguez‐Cerdeira, C., & Eckhardt, W. (2024) · Microorganisms · doi:10.3390/microorganisms12122615 · Cited by 7
Common aspects of neuroplasticity, stress, mood disorders and mitochondrial functions
Hroudová, J., & Karlovu, K. (2010) · Cited by 7
Decreased Resting-State Alpha Self-Synchronization in Depressive Disorder
Mohammadi, Y., Kafraj, M. S., Graversen, C., & Moradi, M. H. (2023) · Clinical EEG and Neuroscience · doi:10.1177/15500594231163958 · Cited by 6
Leserri, S., Amil, A. S., Nowacki, A., Debove, I., Petermann, K., Schäppi, L., Preti, M. G., Ville, D. V. D., Pollo, C., Walther, S., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01683-x · Cited by 6
Lin, Y., Lin, H.-P., Lu, K., Huang, Y., Panyod, S., Liu, W.-T., Lu, Y.-S., Chen, M.-H., & Sheen, L. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.05.003 · Cited by 6
Yang, H., Chen, Y., Tao, Q., Shi, W., Tian, Y. Q., Wei, Y., Li, S., Zhang, Y., Han, S., & Cheng, J. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111052 · Cited by 6
Fluoxetine Increases the Expression of NCAM140 and pCREB in Rat C6 Glioma Cells
Choi, M., Oh, D. H., Kim, S. H., Jung, K. H., Das, N. D., & Chai, Y. G. (2012) · Psychiatry Investigation · doi:10.4306/pi.2012.9.2.180 · Cited by 6
Lin, Y., Lu, K., & Sheen, L. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0137-2 · Cited by 6
Molloy, E. N., Zsido, R. G., Piecha, F. A., Beinhölzl, N., Scharrer, U., Zheleva, G., Regenthal, R., Sehm, B., Nikulin, V. V., Möller, H. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94009-7 · Cited by 7
The efficacy of treatments for depression used in the management of tinnitus
McFerran, D. J., & Baguley, D. (2008) · Hearing Balance and Communication · doi:10.1080/16513860801945224 · Cited by 8
Race et médecine: Une vieille histoire
Doron, C.-O. (2013) · médecine/sciences · doi:10.1051/medsci/20132910022 · Cited by 6
Édes, A. E., McKie, S., Szabó, E., Kökönyei, G., Pap, D., Zsombók, T., Hullám, G., Gonda, X., Kozák, L. R., McFarquhar, M., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107807 · Cited by 6
Ginsenoside Rg1: A natural triterpenoid glycoside with promising anti-depressive properties
Wang, Y., Jiang, J.-J., & Zhang, Y. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.105940 · Cited by 5
Cirulli, F., & Berry, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5605-6_10 · Cited by 6
Rubart, A., Hohagen, F., & Zurowski, B. (2018) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-0598-4972 · Cited by 5
Modulation of premotor cortex response to sequence motor learning during escitalopram intake
Molloy, E. N., Mueller, K., Beinhölzl, N., Blöchl, M., Piecha, F. A., Pampel, A., Steele, C. J., Scharrer, U., Zheleva, G., Regenthal, R., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20965161 · Cited by 6
Role of neural oscillations in depression: highlights on gamma oscillations
Yin, Y., & Li, Y. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03991-x · Cited by 4
Neurotransmission in Mood Disorders
Fiar, Z., Hroudov, J., & Raboch, J. (2012) · InTech eBooks · doi:10.5772/31831 · Cited by 4
Müller, L. G., Biojone, C., Sales, A. J., Betti, A. H., Herzfeldt, V., Joca, S. R. L., & Rates, S. M. K. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000534 · Cited by 4
Bins, H. D. D. C., Panichi, R. M. D., Taborda, J., & Ferrão, Y. A. (2020) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2020.101574 · Cited by 4
Umemori, J., Didio, G., Winkel, F., Pou, M. L., Harkki, J., Russo, G. L., Verie, M., Antila, H., Buj, C., Taira, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.14.431126 · Cited by 5
Emotional Disorders in Development
Price, R. B., & Woody, M. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00024-4 · Cited by 4
More and Less Fear in Serotonin Transporter Knockout Mice
Lima, J., Panayi, M. C., Sharp, T., McHugh, S., & Bannerman, D. (2025) · Genes, Brain and Behavior · doi:10.1111/gbb.70016 · Cited by 3
Henckaerts, P., Fehér, K. D., Hertenstein, E., Schneider, C. L., Angelillo, M., Mikutta, C., Feige, B., Riemann, D. W., & Nissen, C. (2025) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2025.102141 · Cited by 4
Zhao, J., Ouyang, Y., Hu, S., Tian, G., Kong, X., Pan, F., Wu, H., Tang, L., & Yang, H. (2024) · Science of Traditional Chinese Medicine · doi:10.1097/st9.0000000000000044 · Cited by 3
Serra, M. P., Boi, M., Lai, Y., Trucas, M., Fernández‐Teruel, A., Corda, M. G., Giorgi, O., & Quartu, M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173901 · Cited by 3
Integrating the Science of Addiction and the Science of Wellbeing
Gilley, E. (2017) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000275 · Cited by 4
Stress, Inflammation and Neurogenesis in Major Depression
Kim, Y. K. (2011) · Cited by 3
Bergeron, V., & Matthen, M. (2006) · Canadian Journal of Philosophy Supplementary Volume · doi:10.1353/cjp.2007.0039 · Cited by 3
高宮, 明., Ryo, U. E. D. A., Kamiya, K., 田島, 美., Kyuragi, Y., Suwa, T., Noda, T., Kodaka, F., Murai, T., Nakagome, K., et al. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20251330 · Cited by 2
Живолупов, С. А., Samartsev, I. N., Марченко, А. А., & Pulyatkina, O. V. (2013) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-013-9820-2 · Cited by 2
Toward Molecular Psychotherapy of Depression?
Lehtonen, J., Tiihonen, J., Joensuu, M., Lehto, S. M., Ahola, P., Saarinen, P., Valkonen‐Korhonen, M., Tolmunen, T., & Kuikka, J. T. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-792-1_12 · Cited by 3
Early environmental manipulations and long‐term effects on brain neurotrophin levels
Cirulli, F., & Alleva, E. (2016) · Wiley eBooks · doi:10.1002/9781118931684.ch7 · Cited by 2
Vanicek, T., Reed, M. B., Seiger, R., Godbersen, G. M., Klöbl, M., Unterholzner, J., Spurny‐Dworak, B., Gryglewski, G., Handschuh, P. A., Schmidt, C., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221132085 · Cited by 4
Aigbomian, O. E. (2022) · Biotechnologia Acta · doi:10.15407/biotech15.05.047 · Cited by 2
NeuropsychopharmARCology: Shaping Neuroplasticity through Arc/ Arg3.1 Modulation
Mottarlini, F., Caffino, L., Fumagalli, F., Calabrese, F., & Brivio, P. (2024) · Current Neuropharmacology · doi:10.2174/011570159x338335240903075655 · Cited by 3
Portillo, R., Synova, T., & Štaud, F. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112579 · Cited by 2
Affektive Störungen und Suizidalität
Berking, M., & Rief, W. (2012) · Springer-Lehrbuch · doi:10.1007/978-3-642-16974-8_4 · Cited by 3
Yang, C., Zhang, Z., Ma, J., & Chen, T. (2018) · PubMed Central · Cited by 2
Kavalidou (2013) · Journal of Neurology Research · doi:10.4021/jnr171e · Cited by 2
Sipilä, S. T. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 2
Neurotrophins and neuronal plasticity in the action of antidepressants and morphine
Sairanen, M. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 2
Neurocognitive and endocrine dysfunction in women with exhaustion syndrome
Sandström, A. (2010) · DiVA at Umeå University (Umeå University) · Cited by 8
Brain TrkB neurotrophin receptor as a target for antidepressant treatments
Rantamäki, T. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 5
Depressive Disorders in Primary Health Care
Vuorilehto, M. S. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 7
Functional and Work Disability and Treatment Received by Patients with Major Depressive Disorder
Rytsälä, H. J. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 2
Alterations in Neural Structures as Risk Factors for Depression
Ramasubbu, R., & MacQUEEN, G. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-08-045078-0.00003-4 · Cited by 7
Stimulus-specific Synaptic Plasticity in Bipolar II Disorder
Waage, T. R. (2012) · NVA (Nasjonalt vitenarkiv) · Cited by 3
Single-nucleotide polymorphism profiling of 22 candidate genes in mood and anxiety disorders
Koido, K. (2005) · DSpace repository (University of Tartu) · Cited by 29
Effects of Duloxetine on Oxidant-Antioxidant System in Rat Brain Tissues
KARAKUŞ, K., Demirci, K., Uz, E., YİĞİT, A., & Özçankaya, R. (2023) · Phoenix Medical Journal · doi:10.38175/phnx.1383064 · Cited by 1
Die Geschichte des medizinischen Modells der Depression – mit (fast) all ihren Vor- und Nachteilen
Padberg, T., & Plöderl, M. (2025) · Kontext · doi:10.13109/kont.2025.56.2.125 · Cited by 1
NCAM140 and pCREB Expression after Tianeptine Treatment of SH-SY5Y Cells
Lee, M., Oh, D., Choi, M., Chai, Y.-G., Kim, S. H., Oh, D.-H., & Choi, J. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.3.313 · Cited by 1
Effects of long-term fluoxetine treatment on adrenergic plasticity in rat vas deferens
Souza, C. F., Garcez‐do‐Carmo, L., Conceição, I. M., Freitas, T. A., & Frussa‐Filho, R. (2014) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502014000400011 · Cited by 1
Lucassen, P. J., Fitzsimons, C. P., Vreugdenhil, E., Hu, P., Oomen, C. A., Revsin, Y., Joëls, M., & de Kloet, E. R. (2011) · Wiley eBooks · doi:10.1002/9783527633968.ch6 · Cited by 1
Can a systems approach produce a better understanding of mood disorders?
Plant, N. J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.08.016 · Cited by 1
Reward Processing in Motivational and Affective Disorders
Skandali, N. (2016) · Frontiers research topics · doi:10.3389/978-2-88919-986-0 · Cited by 1
Zsido, R. G., Molloy, E. N., Cesnaite, E., Zheleva, G., Regenthal, R., Villringer, A., Nikulin, V. V., & Sacher, J. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.326 · Cited by 1
Impaired mitochondrial bioenergetics in psychiatric disorders
Petschner, P., Gál, Z., & Gonda, X. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00008-5 · Cited by 1
Circadian rhythmicity and depression.
Pregelj, P. (2008) · Slovenian Medical Journal · Cited by 3
Die Neurobiologie der Depression - im Fokus: Imaging Genetics
Pezawas, L., Moser, U., & Kasper, S. F. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Depression, Anxiety, Psychiatric Comorbidity and Dimensions of Temperament and Personality
Jylhä, P. J. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 5
A role for NCAM in depression and antidepressant actions? (Commentary on Aonurm‐Helm et al.)
Sandi, C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06504.x · Cited by 1
Lazowski, L. (2009) · QSpace (Queen's University Library) · Cited by 1
de la Tremblaye, P. B. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5842 · Cited by 1
Activation of the TrkB Neurotrophin Receptor by Antidepressant Drugs
Antila, H. (2016) · Helda - University of Helsinki Institutional Repository · Cited by 1
[Heart involvement in patients with multiple myeloma based on echocardiographic data].
Бессмелъцев, С. С., & Km, A. (1991) · PubMed · Cited by 3
Čulig, L., Steadman, P. E., Kenney, J. W., Legendre, S., Minier, F., Hen, R., Frankland, P. W., & Belzung, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.15.152553 · Cited by 2
Effects of Escitalopram and Relearning on Cortical and Subcortical Grey Matter in Healthy HumansPreprint
Vanicek, T., Reed, M. B., Seiger, R., Godbersen, G. M., Klöbl, M., Unterholzner, J., Spurny‐Dworak, B., Gryglewski, G., Handschuh, P. A., Kraus, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.24.440965 · Cited by 1
Dunlop, B. W., & Nemeroff, C. B. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb002055 · Cited by 1
Molecular and cellular neuroplasticity in animal models of depression
van Bokhoven, P. (2011) · Pure Amsterdam UMC
Metadata
- Authors
- Castrén, E.
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-03
- Volume
- 6
- Issue
- 3
- Pages
- 241-246
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W1985237413
- Cited by
- 563
- References
- 66
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 17 · 2023: 14 · 2022: 17 · 2021: 21 · 2020: 24 · 2019: 14 · 2018: 27 · 2017: 24 · 2016: 33 · 2015: 20 · 2014: 27 · 2013: 33 · 2012: 42
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- depression, mood disorders, antidepressants, neural information processing, artificial neural networks, neuroplasticity, neuronal connectivity, mood recovery
- MeSH terms
- Affect, Animals, Brain Chemistry, Humans, Models, Neurological, Biogenic Monoamines, Neural Networks, Computer, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.